CLGN

Across TCGA pan-cancer cohorts, CLGN Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated CLGN data layer compared with 22 for mass-spec protein and 6 for mass-spec protein.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher CLGN Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated CLGN expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

LUSC, HNSC, and UCEC are the cancer types where CLGN Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Median	II,III,IV	0.001	0.743	<.001	36	view →
HNSC	DFS	Median	All	0.161	0.710	.007	24	view →
UCEC	DFS	Median	All	0.961	0.619	.016	22	view →
OV	DFS	Median	All	0.261	0.541	.017	18	view →
SKCM	OS	Median	III,IV	0.572	0.849	.028	2	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

CLGN–LUSC (OS)

Open the LUSC breakdown →